{"id":"https://openalex.org/W2885849903","doi":"https://doi.org/10.1158/1538-7445.am2018-575","title":"Abstract 575: Prediction of genomic instability in triple-negative breast cancer patients utilizing a CTC phenotype classifier","display_name":"Abstract 575: Prediction of genomic instability in triple-negative breast cancer patients utilizing a CTC phenotype classifier","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2885849903","doi":"https://doi.org/10.1158/1538-7445.am2018-575","mag":"2885849903"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2018-575","doi":"https://doi.org/10.1158/1538-7445.am2018-575","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-575","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5066167344","display_name":"Adam Jendrisak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adam Jendrisak","raw_affiliation_strings":["Epic Sciences, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, San Diego, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029646201","display_name":"Nadia Ebrahim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadia Ebrahim","raw_affiliation_strings":["Epic Sciences, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, San Diego, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090576464","display_name":"Angel Augusto Rodriguez","orcid":"https://orcid.org/0000-0003-0735-3039","observed_orcids":["https://orcid.org/0000-0003-0735-3039"]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angel Rodriguez","raw_affiliation_strings":["Epic Sciences, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, San Diego, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100628097","display_name":"Jerry S. H. Lee","orcid":"https://orcid.org/0000-0003-1515-0952","observed_orcids":["https://orcid.org/0000-0003-1515-0952"]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerry Lee","raw_affiliation_strings":["Epic Sciences, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, San Diego, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011056242","display_name":"Ramsay Sutton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ramsay Sutton","raw_affiliation_strings":["Epic Sciences, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, San Diego, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Yipeng Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yipeng Wang","raw_affiliation_strings":["Epic Sciences, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, San Diego, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112098169","display_name":"Mark Andrew Landers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Landers","raw_affiliation_strings":["Epic Sciences, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, San Diego, CA","institution_ids":["https://openalex.org/I4210159579"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5022442590","display_name":"Ryan Vance Dittamore","orcid":"https://orcid.org/0000-0003-2281-3232","observed_orcids":["https://orcid.org/0000-0003-2281-3232"]},"institutions":[{"id":"https://openalex.org/I4210159579","display_name":"Epic Sciences (United States)","ror":"https://ror.org/0527cde49","country_code":"US","type":"company","lineage":["https://openalex.org/I4210159579"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ryan Dittamore","raw_affiliation_strings":["Epic Sciences, San Diego, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Epic Sciences, San Diego, CA","institution_ids":["https://openalex.org/I4210159579"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210159579"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":"13_Supplement","first_page":"575","last_page":"575"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.8583999872207642,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.04280000180006027,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.022299999371170998,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/genomic-instability","display_name":"genomic instability","score":0.9409999847412109},{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":1.0},{"id":"https://openalex.org/keywords/circulating-tumor-cells","display_name":"circulating tumor cells","score":0.996999979019165},{"id":"https://openalex.org/keywords/single-cell-sequencing","display_name":"single-cell sequencing","score":0.6470000147819519},{"id":"https://openalex.org/keywords/linear-regression-prediction-model","display_name":"linear regression prediction model","score":0.6110000014305115},{"id":"https://openalex.org/keywords/parp-inhibitor-response","display_name":"PARP inhibitor response","score":0.7170000076293945},{"id":"https://openalex.org/keywords/metastatic-castration-resistant-prostate-cancer","display_name":"metastatic castration-resistant prostate cancer","score":0.753000020980835},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.4880000054836273},{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.5950000286102295},{"id":"https://openalex.org/keywords/veliparib","display_name":"veliparib","score":0.9919999837875366},{"id":"https://openalex.org/keywords/intertumoral-heterogeneity","display_name":"intertumoral heterogeneity","score":0.5059999823570251}],"concepts":[{"id":"https://openalex.org/C61238886","wikidata":"https://www.wikidata.org/wiki/Q5121689","display_name":"Circulating tumor cell","level":4,"score":0.7186510562896729},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.6259008646011353},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.62295001745224},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5714074373245239},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5122081637382507},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5006561279296875},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.44126126170158386},{"id":"https://openalex.org/C127716648","wikidata":"https://www.wikidata.org/wiki/Q104053","display_name":"Phenotype","level":3,"score":0.41714558005332947},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3210671842098236},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.22421085834503174},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.18704506754875183},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.1649273931980133},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.11446130275726318}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2018-575","doi":"https://doi.org/10.1158/1538-7445.am2018-575","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2018-575","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2512653841","https://openalex.org/W3006466651","https://openalex.org/W2890266803","https://openalex.org/W2946987094","https://openalex.org/W2760836510","https://openalex.org/W3179015708","https://openalex.org/W2590895980","https://openalex.org/W2875812543","https://openalex.org/W4402196002","https://openalex.org/W2402999020"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Genomic":[2],"scars":[3],"and":[4,14,41,48,107,124,152,163,198,223,368],"HRD":[5],"gene":[6],"mutations":[7],"are":[8,26],"biomarkers":[9],"for":[10,23,129,154,172,221,226,231,350,415],"PARP":[11],"inhibitor":[12],"(PARPi)":[13],"platinum":[15,112,311],"agent":[16],"therapy":[17,312],"response":[18,313],"in":[19,69,133,236,314,332,370,398],"breast":[20,400],"cancer.":[21],"Tests":[22],"these":[24],"markers":[25],"usually":[27],"performed":[28],"by":[29,191,241],"next-generation":[30],"sequencing":[31],"(NGS)":[32],"of":[33,67,175,182,216,243,356,373,395,411],"tumor":[34,38],"tissue":[35],"or":[36,310],"circulating":[37],"DNA":[39],"(ctDNA)":[40],"have":[42],"limitations":[43],"such":[44],"as":[45,179,259],"sample":[46],"accessibility/availability":[47],"under-sampling":[49],"due":[50],"to":[51,111,122,188,200,307,327,340,360],"inter/intratumor":[52],"heterogeneity.":[53],"Previously":[54],"we":[55,120,318],"predicted":[56,87,225],"genomic":[57,396],"instability":[58,397],"(GI)":[59],"using":[60,344],"CTC":[61,131,150,192,203,347,351,405],"phenotypic":[62,156],"features":[63],"without":[64,353],"the":[65,147,173,237,257,276,320,354,371,412],"use":[66,355],"NGS":[68,357],"metastatic":[70],"castration-resistant":[71],"prostate":[72],"cancer":[73,401],"(mCRPC)":[74],"pts":[75,143],"with":[76,85,146,304],"high":[77,249],"accuracy":[78,272,290],"(>76%)":[79],"(ASCO":[80],"2016).":[81],"In":[82,275],"addition,":[83],"patients":[84,362,402],"phenotypically":[86,224],"GI":[88,190,222,232,250,282],"(pGI)":[89],"CTCs":[90,139,168,209],"had":[91],"significantly":[92],"better":[93,110],"PSA":[94],"responses":[95],"on":[96],"abiraterone":[97,102],"+":[98],"veliparib":[99],"(92%)":[100],"vs.":[101,114,248,281],"alone":[103],"(23%)":[104],"(ESMO":[105,117],"2016),":[106],"also":[108],"responded":[109],"agents":[113,116],"taxane":[115],"2017).":[118],"Here,":[119],"sought":[121],"develop":[123],"analytically":[125,301],"validate":[126],"an":[127,180,300,345],"algorithm":[128,187],"predicting":[130],"pGI":[132,204,252,280,298],"TNBC.":[134,328],"Methods:":[135],"Training":[136],"set:":[137,207],"521":[138],"from":[140,210],"26":[141],"mCRPC":[142,238,315],"were":[144,169,219],"detected":[145],"Epic":[148],"Sciences":[149],"platform":[151],"analyzed":[153],"19":[155],"digital":[157],"pathology":[158],"features,":[159],"including":[160],"protein":[161],"expression":[162],"cell":[164],"morphology.":[165],"The":[166,261,338],"same":[167,258,321],"single-cell":[170],"sequenced":[171,220],"number":[174],"large-scale":[176],"transitions":[177],"(LSTs)":[178],"indicator":[181],"GI.":[183,260],"A":[184],"linear":[185],"regression":[186],"predict":[189,308],"phenotype":[193,352,406],"was":[194,234,255,299],"developed,":[195],"cross":[196],"validated,":[197],"utilized":[199],"generate":[201],"a":[202,244,333,404],"score.":[205],"Test":[206],"114":[208],"8":[211,217],"TNBC":[212,277],"blood":[213],"samples,":[214],"median":[215],"CTCs/pt,":[218],"pGI.":[227],"Results:":[228],"Analytical":[229],"cutoff":[230,253],"(8.74)":[233,254],"determined":[235],"training":[239,262],"set":[240,256,263],"separation":[242],"binomial":[245],"distribution":[246],"low":[247],"scores.":[251],"performance":[264],"was:":[265],"sensitivity":[266,284,343],"=":[267,270,273,285,288,291],"69%,":[268],"specificity":[269,287],"83%,":[271],"77%.":[274],"test":[278,322],"set,":[279],"demonstrated:":[283],"86%,":[286],"92%,":[289],"88%.":[292],"Conclusions:":[293],"Previous":[294],"studies":[295],"showed":[296],"that":[297],"validated":[302],"biomarker":[303],"clinical":[305],"utility":[306],"PARPi":[309],"pts.":[316],"Here":[317],"show":[319],"concept":[323],"can":[324],"be":[325],"applied":[326],"Further":[329],"analytical":[330],"validation":[331],"larger":[334],"cohort":[335],"is":[336],"ongoing.":[337],"ability":[339],"identify":[341],"PARPi/platinum":[342],"IF":[346],"staining":[348],"method":[349],"will":[358],"help":[359],"stratify":[361],"more":[363],"rapidly,":[364],"at":[365],"reduced":[366],"cost,":[367],"aid":[369],"acceleration":[372],"drug":[374],"development.":[375],"Citation":[376],"Format:":[377],"Adam":[378],"Jendrisak,":[379],"Nadia":[380],"Ebrahim,":[381],"Angel":[382],"Rodriguez,":[383],"Jerry":[384],"Lee,":[385],"Ramsay":[386],"Sutton,":[387],"Yipeng":[388],"Wang,":[389],"Mark":[390],"Landers,":[391],"Ryan":[392],"Dittamore.":[393],"Prediction":[394],"triple-negative":[399],"utilizing":[403],"classifier":[407],"[abstract].":[408],"In:":[409],"Proceedings":[410],"American":[413],"Association":[414],"Cancer":[416,429],"Research":[417],"Annual":[418],"Meeting":[419],"2018;":[420],"2018":[421],"Apr":[422],"14-18;":[423],"Chicago,":[424],"IL.":[425],"Philadelphia":[426],"(PA):":[427],"AACR;":[428],"Res":[430],"2018;78(13":[431],"Suppl):Abstract":[432],"nr":[433],"575.":[434]},"counts_by_year":[],"updated_date":"2026-09-22T06:50:58.402377","created_date":"2018-08-22T00:00:00"}